AAA
Affinity Asset Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50,000
| Closed | -$1.6M | – | 84 |
|
|
2024
Q4 | $1.6M | Buy |
+50,000
| New | +$1.6M | 0.21% | 57 |
|
|
2024
Q2 | – | Sell |
-165,000
| Closed | -$9.7M | – | 92 |
|
|
2024
Q1 | $9.7M | Buy |
165,000
+90,000
| +120% | +$5.29M | 1.2% | 21 |
|
|
2023
Q4 | $4.49M | Buy |
75,000
+35,000
| +88% | +$2.1M | 0.82% | 30 |
|
|
2023
Q3 | $1.52M | Buy |
40,000
+30,000
| +300% | +$1.14M | 0.43% | 42 |
|
|
2023
Q2 | $911K | Sell |
10,000
-25,000
| -71% | -$2.28M | 0.32% | 47 |
|
|
2023
Q1 | $2.31M | Buy |
+35,000
| New | +$2.31M | 0.76% | 32 |
|
|
2021
Q3 | – | Sell |
-10,000
| Closed | -$632K | – | 68 |
|
|
2021
Q2 | $632K | Buy |
+10,000
| New | +$632K | 0.23% | 58 |
|